These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24740913)

  • 1. Self-propelled Janus mesoporous silica nanomotors with sub-100 nm diameters for drug encapsulation and delivery.
    Xuan M; Shao J; Lin X; Dai L; He Q
    Chemphyschem; 2014 Aug; 15(11):2255-60. PubMed ID: 24740913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus-responsive nanomotors based on gated enzyme-powered Janus Au-mesoporous silica nanoparticles for enhanced cargo delivery.
    Llopis-Lorente A; García-Fernández A; Lucena-Sánchez E; Díez P; Sancenón F; Villalonga R; Wilson DA; Martínez-Máñez R
    Chem Commun (Camb); 2019 Oct; 55(87):13164-13167. PubMed ID: 31620732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-propelled enzyme-controlled IR-mesoporous silica Janus nanomotor for smart delivery.
    Mayol B; Pradana-López S; García A; de la Torre C; Díez P; Villalonga A; Anillo C; Vilela D; Sánchez A; Martínez-Ruiz P; Martínez-Máñez R; Villalonga R
    J Colloid Interface Sci; 2024 Oct; 671():294-302. PubMed ID: 38815366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
    He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
    Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-Powered Gated Mesoporous Silica Nanomotors for On-Command Intracellular Payload Delivery.
    Llopis-Lorente A; García-Fernández A; Murillo-Cremaes N; Hortelão AC; Patiño T; Villalonga R; Sancenón F; Martínez-Máñez R; Sánchez S
    ACS Nano; 2019 Oct; 13(10):12171-12183. PubMed ID: 31580642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic mesoporous Janus nanomotors for active cargo delivery.
    Ma X; Hahn K; Sanchez S
    J Am Chem Soc; 2015 Apr; 137(15):4976-9. PubMed ID: 25844893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
    Ran Z; Sun Y; Chang B; Ren Q; Yang W
    J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
    Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
    ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
    Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
    J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.